SESSION VII SCHEDULE
SESSION VII: TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
x
6:40 AM - 6:47 AM Is Carotid Stenting (CAS) Really Contraindicated In Patients Over 80 Years Of Age? Why Is This So?
  Presenters: Michel S. Makaroun, M.D.  
6:48 AM - 6:55 AM Technical Tips For Performing CAS Safely: Which Patients Should Get Endarterectomy (CEA) Based On Angiographic And IVUS Evaluation Of Plaque Morphology?
  Presenters: Mark H. Wholey, M.D.  
6:56 AM - 7:03 AM Evolution Of Proximal Occlusion Embolic Protection Devices: Relative And Absolute Indications And Contraindications
  Presenters: Juan C. Parodi, M.D.  
7:04 AM - 7:11 AM Are Endovascular Procedures Feasible In Infants And Children? What Precautions Or Special Instrumentation Are Needed?
  Presenters: Michael B. Silva, Jr., M.D.  
7:12 AM - 7:19 AM Results Of Celiac And Mesenteric Stenting: Technical Tips And High Recurrence Rates
  Presenters: Jos C. van den Berg, M.D., Ph.D.  
7:20 AM - 7:27 AM Debate: Open AAA Repair Still Has A Major Role In Good Risk Young Patients
  Presenters: Robert B. Rutherford, M.D.  
7:28 AM - 7:35 AM Debate: All Good Risk AAA Patients With Suitable Anatomy Should Be Treated With EVAR
  Presenters: Edward B. Diethrich, M.D.  
7:36 AM - 7:45 AM Panel Discussion
END OF SESSION VII
 
SESSION VIII SCHEDULE
SESSION VIII: MORE TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
x
7:45 AM - 7:52 AM Debate: Neck Enlargement After EVAR Is Common And Has Dire Consequences
  Presenters: Piergiorgio Cao, M.D.  
7:53 AM - 8:00 AM Debate: Neck Enlargement After EVAR Is Rare And Benign
  Presenters: James May, M.D., M.S., F.R.A.C.S., F.A.C.S.  
8:01 AM - 8:08 AM Technique And Importance Of Duplex Surveillance After SFA Stenting: Does It Make A Difference?
  Presenters: Dennis F. Bandyk, M.D.  
8:09 AM - 8:16 AM One-Year Results Of The FAST Trial For The Treatment Of SFA Disease
  Presenters: Hans Krankenberg, M.D.  
8:17 AM - 8:24 AM Role Of Cutting Balloons For De Novo And Recurrent Lesions
  Presenters: Peter A. Schneider, M.D.  
8:25 AM - 8:34 AM Panel Discussion
END OF SESSION VIII
 
SESSION IX SCHEDULE
SESSION IX: NEW HORIZONS AND OPPORTUNITIES FOR CARDIAC SURGEONS (7-MINUTE TALKS)
Moderators:Bruce Lytle, M.D.
x
8:35 AM - 8:42 AM Endovascular Approaches To Mitral Valve Disease
  Presenters: Ted Feldman, M.D.  
8:43 AM - 8:50 AM Endovascular Pulmonic Valve Replacement
  Presenters: Philipp Bonhoeffer, M.D.  
8:51 AM - 8:58 AM Functional Replacement For Tricuspid Insufficiency: An Endovascular Approach
  Presenters: Roy K. Greenberg, M.D.  
8:59 AM - 9:06 AM Experience With Percutaneous Aortic Valve Replacement: Future Potential
  Presenters: Martin B. Leon, M.D.  
9:07 AM - 9:14 AM Implications Of The Aortic Valve On Endovascular Repairs Of The Ascending Aorta
  Presenters: Timothy A.M. Chuter, M.D.  
9:15 AM - 9:22 AM Hybrid (Open/Endo) Approaches For Repair Of Ascending And Arch Aneurysms
  Presenters: Bruce Lytle, M.D.  
9:23 AM - 9:30 AM Debate: Endovascular Treatment Of Adult Coarctation And Its Complications: The Best Treatment For Most Patients
  Presenters: Christoph A. Nienaber, M.D.  
9:31 AM - 9:38 AM Debate: Current Status Of Treatment For Adult Coarctation: Open Surgery Is Still The Best Treatment For Most Patients
  Presenters: Joseph E. Bavaria, M.D.  
9:39 AM - 9:49 AM Panel Discussion
END OF SESSION IX
 
SESSION X SCHEDULE
SESSION X: SUPERFICIAL FEMORAL ARTERY (SFA) AND CRURAL ARTERY TREATMENT: STATE-OF-THE-ART AND NEW ADJUNCTS (6- AND 7-MINUTE TALKS)
x
9:50 AM - 9:57 AM Natural History Of Patients With Arterial Insufficiency And Non-Healing Ulcers Treated Conservatively: How Does It Impact On Limb Salvage Results With Aggressive New Endo-Interventions And Are We Being Fooled Into Over-Treating?
  Presenters: Blair A. Keagy, M.D.  
9:58 AM - 10:05 AM Outcomes Of Infrainguinal Intervention: Beyond The Hype And Baloney - What Really Works And What Does Not?
  Presenters: Alan T. Hirsch, M.D.  
10:06 AM - 10:13 AM PTA vs. Stenting Of The SFA: Results Of The Resilient Randomized Trial
  Presenters: Barry T. Katzen, M.D.  
10:14 AM - 10:21 AM How To Avoid Fractures In SFA Stents And Will It Improve Results: Are Absorbable Stents The Answer?
  Presenters: Giancarlo Biamino, M.D.  
10:22 AM - 10:28 AM Role Of SFA Stents In 2006: How Well Do They Work?
  Presenters: Mark W. Mewissen, M.D.  
10:29 AM - 10:35 AM Do We Have The Right Stents For Femoropopliteal Lesions And 2-3 Year Results Of A Randomized Trial Comparing Absorbable Metal Stents To PTA Alone In Crural Arteries?
  Presenters: Marc Bosiers, M.D.  
10:36 AM - 10:42 AM 3-Year Trial Results Of Zilver Nitinol Stents For Long SFA Lesions (TASC C And D)
  Presenters: Marcelo Ferreira, M.D.  
10:43 AM - 10:49 AM Update On The Value And Limitations Of The Silverhawk Rotational Atherectomy Device For Treatment Of Infrainguinal Disease
  Presenters: Venkatesh G. Ramaiah, M.D.  
10:50 AM - 10:56 AM Midterm Results Of Rotational Atherectomy In Patients With TASC C Lesions Treated For Critical Ischemia
  Presenters: David J. Minion, M.D.  
10:57 AM - 11:03 AM Role Of Lasers In The Treatment Of Lower Extremity Occlusive Disease: Is There A Place After All?
  Presenters: John R. Laird, M.D.  
11:04 AM - 11:14 AM Panel Discussion
END OF SESSION X
 
SESSION XI SCHEDULE
SESSION XI: CRITICAL LOOK AT CAROTID STENTING (CAS) (6-MINUTE TALKS)
x
11:15 AM - 11:21 AM Debate: Carotid Interventions Are Justified In High Risk Asymptomatic Patients: Of Course They Are
  Presenters: Frank J. Criado, M.D.  
11:22 AM - 11:28 AM Debate: Why Interventions (CAS And CEA) Are Rarely Justified And Indicated In High Risk Asymptomatic Patients
  Presenters: Geoffrey L. Gilling-Smith, M.S., F.R.C.S.  
11:29 AM - 11:35 AM Is It Justified And Ethical To Perform CAS In Asymptomatic Patients? Will We Ever Know?
  Presenters: Alison Halliday, M.S., F.R.C.S.  
11:36 AM - 11:42 AM The Asymptomatic Carotid Trials: How Can The Results Be Interpreted So Differently And Should Asymptomatic Patients Really Be Treated?
  Presenters: A. Ross Naylor, M.D., F.R.C.S.  
11:43 AM - 11:50 AM In Asymptomatic Patients, What Is A High Risk Plaque If We Intervene? If We Treat Conservatively? What Should We Do?
  Presenters: Giorgio M. Biasi, M.D.  
11:51 AM - 11:57 PM Embolic Protection Devices In CAS Remain Unproven And Are Much Ado About Nothing
  Presenters: Emmanuel M. Houdart, M.D.  
11:58 AM - 12:04 PM Randomized Prospective Trial Of Embolic Protection Devices In CAS
  Presenters: Michel S. Makaroun, M.D.  
12:05 PM - 12:11 PM CAS vs. CEA In Symptomatic Carotid Stenosis Patients: Early Results Of The French Randomized Study (EVA-3S)
  Presenters: Jean-Pierre Becquemin, M.D., F.R.C.S.  
12:12 PM - 12:18 PM A New Technique To Reduce Guidewire Manipulation During Carotid Artery Stenting: The Superficial Temporal Artery Approach
  Presenters: Can't open file: './veithsym/faculty2006.frm' (errno: 24)